Related references
Note: Only part of the references are listed.Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004
Monica Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Evaluating Cancer Epidemiologic Risk Factors Using Multiple Primary Malignancies
Ekatherina Kuligina et al.
EPIDEMIOLOGY (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
The molecular pathology of cancer
Timothy J. R. Harris et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis
G. K. Reeves et al.
BRITISH JOURNAL OF CANCER (2009)
Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non-Small Cell Lung Cancers
Nicolas Girard et al.
CLINICAL CANCER RESEARCH (2009)
Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling
Irene Orlow et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status
Montserrat Garcia-Closas et al.
CLINICAL CANCER RESEARCH (2008)
Searching for susceptibility alleles: Emphasis on bilateral breast cancer
Evgeny N. Imyanitov et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Bilateral breast cancer: Differential diagnosis using histological and biological parameters
Soo Jung Gong et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer
Wendy Y. Chen et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Differences in risk factors for breast cancer molecular subtypes in a population-based study
Xiaohong R. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen
G Arpino et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A comparison of bilateral breast cancers in BRCA carriers
JN Weitzel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts
A Stark et al.
BREAST JOURNAL (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer
SM Swain et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Phenotypic similarities in bilateral breast cancer
J Kollias et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
The molecular biology of mucosal field cancerization of the head and neck
PK Ha et al.
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2003)
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies
C Hafner et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas
EN Imyanitov et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh et al.
CANCER CELL (2002)
High constant incidence in twins and other relatives of women with breast cancer
J Peto et al.
NATURE GENETICS (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)